nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—ADRA2A—G alpha (i) signalling events—C3—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RDH8—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RPE65—age related macular degeneration	0.00172	0.00172	CbGpPWpGaD
Ergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00171	0.00171	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—RHO—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ELOVL4—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Ergotamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—RHO—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Ergotamine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ABCA4—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Ergotamine—HTR2B—GPCR ligand binding—C3—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—RHO—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RDH8—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—C3—age related macular degeneration	0.0016	0.0016	CbGpPWpGaD
Ergotamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RPE65—age related macular degeneration	0.00158	0.00158	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—RHO—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RPE65—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Ergotamine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Ergotamine—HTR1A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR ligand binding—C3—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Ergotamine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00153	0.00153	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RPE65—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—C3—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ABCA4—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TGFBR1—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Ergotamine—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—C3—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—RHO—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ABCA4—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Ergotamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RPE65—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Ergotamine—HTR1D—GPCR ligand binding—CCL2—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TGFBR1—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—C3—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Ergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Ergotamine—HTR1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ABCA4—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Ergotamine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—C3—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—SLC16A8—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—SQSTM1—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—C3—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Ergotamine—HTR2A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—C3—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Ergotamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—CD36—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—RHO—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Ergotamine—HTR2B—GPCR ligand binding—CCL2—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—C3—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—SQSTM1—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—RHO—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—RHO—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Ergotamine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Ergotamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR ligand binding—CCL2—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RHO—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Ergotamine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Ergotamine—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—C3—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—C3—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—CCL2—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RHO—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—CCL2—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RHO—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—CCL2—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—CCL2—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—C3—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—CCL2—age related macular degeneration	0.001	0.001	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—C3—age related macular degeneration	0.001	0.001	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.000999	0.000999	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000995	0.000995	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.000993	0.000993	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.000951	0.000951	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000944	0.000944	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—C3—age related macular degeneration	0.000939	0.000939	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000935	0.000935	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000931	0.000931	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—C3—age related macular degeneration	0.000927	0.000927	CbGpPWpGaD
Ergotamine—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.000926	0.000926	CbGpPWpGaD
Ergotamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000923	0.000923	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000911	0.000911	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—C3—age related macular degeneration	0.000908	0.000908	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—CCL2—age related macular degeneration	0.000892	0.000892	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000875	0.000875	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—C3—age related macular degeneration	0.000874	0.000874	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000866	0.000866	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000862	0.000862	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—C3—age related macular degeneration	0.000856	0.000856	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—C3—age related macular degeneration	0.000853	0.000853	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000844	0.000844	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000836	0.000836	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000829	0.000829	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000826	0.000826	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.000814	0.000814	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—C3—age related macular degeneration	0.000808	0.000808	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—APOE—age related macular degeneration	0.000797	0.000797	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—C3—age related macular degeneration	0.000794	0.000794	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000793	0.000793	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—C3—age related macular degeneration	0.000789	0.000789	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—KDR—age related macular degeneration	0.000781	0.000781	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.000762	0.000762	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—C3—age related macular degeneration	0.000758	0.000758	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000754	0.000754	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—APOE—age related macular degeneration	0.000752	0.000752	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000738	0.000738	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—KDR—age related macular degeneration	0.000737	0.000737	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000735	0.000735	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000726	0.000726	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—C3—age related macular degeneration	0.000725	0.000725	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000722	0.000722	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000717	0.000717	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—C3—age related macular degeneration	0.000716	0.000716	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—CCL2—age related macular degeneration	0.00071	0.00071	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000709	0.000709	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000706	0.000706	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.000699	0.000699	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000692	0.000692	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000688	0.000688	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000675	0.000675	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000674	0.000674	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CCL2—age related macular degeneration	0.00067	0.00067	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000669	0.000669	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000667	0.000667	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000666	0.000666	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—C3—age related macular degeneration	0.000659	0.000659	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000658	0.000658	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—C3—age related macular degeneration	0.000644	0.000644	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000643	0.000643	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.00064	0.00064	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CCL2—age related macular degeneration	0.000632	0.000632	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—VEGFA—age related macular degeneration	0.000627	0.000627	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000623	0.000623	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000621	0.000621	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000613	0.000613	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000612	0.000612	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000607	0.000607	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.0006	0.0006	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000599	0.000599	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000597	0.000597	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—C3—age related macular degeneration	0.000585	0.000585	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000582	0.000582	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000565	0.000565	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000561	0.000561	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000557	0.000557	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000556	0.000556	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—C3—age related macular degeneration	0.000548	0.000548	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000544	0.000544	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000544	0.000544	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000541	0.000541	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000538	0.000538	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—C3—age related macular degeneration	0.000536	0.000536	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000515	0.000515	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—APOE—age related macular degeneration	0.00051	0.00051	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000505	0.000505	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—C3—age related macular degeneration	0.000504	0.000504	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000502	0.000502	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—KDR—age related macular degeneration	0.0005	0.0005	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—APOE—age related macular degeneration	0.000499	0.000499	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—KDR—age related macular degeneration	0.000489	0.000489	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000483	0.000483	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000476	0.000476	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000475	0.000475	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—APOE—age related macular degeneration	0.000469	0.000469	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—C3—age related macular degeneration	0.000469	0.000469	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000468	0.000468	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CETP—age related macular degeneration	0.000466	0.000466	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—KDR—age related macular degeneration	0.000459	0.000459	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000458	0.000458	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000443	0.000443	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—APOE—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—VEGFA—age related macular degeneration	0.00043	0.00043	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CCL2—age related macular degeneration	0.000429	0.000429	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—KDR—age related macular degeneration	0.000428	0.000428	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000425	0.000425	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—C3—age related macular degeneration	0.000423	0.000423	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CCL2—age related macular degeneration	0.00042	0.00042	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000409	0.000409	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000406	0.000406	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—VEGFA—age related macular degeneration	0.000406	0.000406	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000405	0.000405	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CCL2—age related macular degeneration	0.000394	0.000394	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—APOE—age related macular degeneration	0.000394	0.000394	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—C3—age related macular degeneration	0.000389	0.000389	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—KDR—age related macular degeneration	0.000386	0.000386	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000386	0.000386	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.00038	0.00038	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.000373	0.000373	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000372	0.000372	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000371	0.000371	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCL2—age related macular degeneration	0.000367	0.000367	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—APOE—age related macular degeneration	0.000362	0.000362	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000359	0.000359	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000357	0.000357	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—KDR—age related macular degeneration	0.000355	0.000355	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000353	0.000353	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—C3—age related macular degeneration	0.000346	0.000346	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000334	0.000334	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCL2—age related macular degeneration	0.000331	0.000331	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000329	0.000329	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000327	0.000327	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000322	0.000322	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—APOE—age related macular degeneration	0.000322	0.000322	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000321	0.000321	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.00032	0.00032	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000318	0.000318	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—KDR—age related macular degeneration	0.000315	0.000315	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCL2—age related macular degeneration	0.000304	0.000304	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000299	0.000299	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000298	0.000298	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000293	0.000293	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000287	0.000287	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000281	0.000281	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CD36—age related macular degeneration	0.00028	0.00028	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000276	0.000276	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000275	0.000275	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCL2—age related macular degeneration	0.00027	0.00027	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000269	0.000269	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000253	0.000253	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000251	0.000251	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOE—age related macular degeneration	0.000247	0.000247	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000236	0.000236	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000224	0.000224	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000213	0.000213	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000205	0.000205	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000204	0.000204	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000197	0.000197	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000195	0.000195	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.00018	0.00018	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000177	0.000177	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000174	0.000174	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000173	0.000173	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000161	0.000161	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000152	0.000152	CbGpPWpGaD
